Louvain-la-Neuve, Belgium, 26 January 2022 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceuticals production ...
Louvain-la-Neuve, Belgium, December 20, 2023 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical ...
Louvain-la-Neuve, Belgium– March 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical ...
Cyclone 70 to stabilize United States supply of Strontium 82/Rubidium 82 generators for use in the diagnosis of cardiovascular disease Zevacor Molecular, an independently owned healthcare firm that ...
Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA ...
SAN DIEGO--(BUSINESS WIRE)-- The Centre Antoine-Lacassagne Cancer Center (CAL), in Nice, France, has signed a letter of intent with IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg ...
Proteus ONE™* is a new single-room system that substantially reduces cost, minimizes the space and shortens the installation time required to build a Proton Therapy center. SAN DIEGO--(BUSINESS WIRE)- ...
Medical cyclotron is a machine used in the medical imaging and research field to make relatively short lived radioisotopes. Cyclotron is a particle accelerator. It is an electrically powered machine ...
The Cyclone ® KIUBE is a high-performance cyclotron enabling the production of many radioisotopes used for the diagnosis of cancer and other severe cardiac and neurologic diseases Louvain-la-Neuve, ...
(MENAFN- GlobeNewsWire - Nasdaq) The Cyclone® KIUBE is a high-performance cyclotron enabling the production of many radioisotopes used for the diagnosis of cancer and other severe cardiac and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results